Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004239803 | SCV003748136 | uncertain significance | not specified | 2022-07-11 | criteria provided, single submitter | clinical testing | The c.2623T>A (p.C875S) alteration is located in exon 5 (coding exon 4) of the TLR3 gene. This alteration results from a T to A substitution at nucleotide position 2623, causing the cysteine (C) at amino acid position 875 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003603147 | SCV004508600 | uncertain significance | Herpes simplex encephalitis, susceptibility to, 1 | 2023-06-04 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 2406619). This variant has not been reported in the literature in individuals affected with TLR3-related conditions. This variant is present in population databases (rs146846379, gnomAD 0.002%). This sequence change replaces cysteine, which is neutral and slightly polar, with serine, which is neutral and polar, at codon 875 of the TLR3 protein (p.Cys875Ser). |